Human phosphofructokinase (PFK) exists in tetrameric isozymic forms, at least in vitro. Muscle and liver contain homotetramers M4 and L4, respectively, whereas red cells contain five isozymes composed of M (muscle) and L (liver) type subunits, i.e., M4, M3L, M2L2, and ML3, and L4. Homozygous deficiency of muscle PFK results in the classic glycogen storage disease type VII characterized by exertional myopathy and hemolytic syndrome beginning in early childhood. The genetic lesion results in a total and partial loss of muscle and red cell PFK, respectively. Characteristically, the residual red cell PFK from the patients consists of isolated L4 isozyme; the M-containing hybrid isozymes are completely absent. In this study, we investigated an 80-yr-old man who presented with a 10-yr history of progressive weakness of the lower limbs as the only symptom. The residual red cell PFK showed the presence of a few M-containing isozymes in addition to the predominant L4 species, indicating that the genetic lesion is a "leaky" mutation of the gene coding for the M subunit. The presence of a small amount of enzyme activity in the muscle may account for the atypical myopathy in this patient.
Introduction
Phosphofructokinase (PFK;2 ATP:D-fructose-6-phosphate, 1- phosphotransferase [EC 2.7.1.1 1]), the key regulatory enzyme of glycolysis, is a tetrameric3 protein with a subunit M, of 1. t Deceased. 2. Abbreviations used in this paper: L, liver; M, muscle; P, platelet; PFK, phosphofructokinase. 3. Although the smallest active oligomer of PFK is a tetramer and, under the conditions of ion-exchange chromatography used by us, various isozymes indeed exist as tetramers in vitro, the enzyme most likely exists in a series of oligomeric species in vivo, due to its great propensity for self-aggregation. Thus, the definition of the term tetramer as used in this article is a strictly operational one and is used for the ease of description of the experimental results.
-85,000. We have previously shown that human PFK is under the control of three structural loci that code for three unique subunits, muscle (M), liver (L), and platelet (P) types (1, 2) . A tissue may express one, two, or all three subunits, which randomly tetramerize to form various isozymes. For instance, human muscle and liver (major species) express homotetramers, M4 and L4, respectively, whereas red cells contain five isozymes composed of M and L subunits, M4, M3L, M2L2, ML3, and L4. In contrast, platelet PFK consists of three species composed of P and L subunits, i.e., P4, P3L, P2L2. These isozymes are distinguishable from one another by ionexchange chromatography and subunit-specific monoclonal antibodies (1) (2) (3) .
Inherited deficiency of muscle PFK is known to occur in man and the dog (4) (5) (6) . In man, the enzyme deficiency is associated with a heterogeneous group of clinical syndromes characterized by myopathy and/or hemolysis or asymptomatic state (4, 5) . The most common syndrome, glycogen storage disease type VII, is characterized by the coexistence of muscle disease and hemolytic process. Typically, the muscle disease begins in early childhood and consists of easy fatigability, transient weakness and muscle cramps, and myoglobinuria after vigorous exercise. The genetic lesion(s) in most cases is shown to result in a total lack of the catalytically active muscle-type subunit(s) of PFK (5) . Only one of 20 reported cases presented with a muscle disease of late-onset fixed weakness that was progressive in nature and unassociated with muscle cramps and myoglobinuria (7) . The nature of the enzymatic defect was not investigated in detail.
Recently, we had an opportunity to investigate a patient with late-onset, progressive weakness restricted to the lower limbs (8) . Our studies suggest that the genetic lesion in this patient is distinct from the one causing the classic disease in that the patient exhibits enzymatically active muscle-type subunits, but in a reduced amount. The late-onset muscle disease in the patient may be ascribed to both the residual muscle PFK activity and altered gene expression in the aged. Since lateonset myopathy is now well-documented in three unrelated individuals with muscle PFK deficiency (7, 8 , DiMauro, S., 1985, unpublished results), it is proposed that it be classified as a new subtype of glycogenosis type VII and be considered in the differential diagnosis of late-onset myopathies of unexplained etiology.
Case report. J.K., a retired bus driver, is an 80-yr-old Jew- ish man who presented in the spring of 1984 with the chief complaint of progressive weakness of both lower limbs for the last 10 yr. On examination, the weakness was found to be rather fixed in and around the quadriceps muscles ofboth legs; there was no weakness of shoulder girdle or arm muscles. His shoulder girdle was found to be rather powerful, in sharp con-trast to his legs, which appeared dystrophic. Although he gave a history of easy fatigability and inability to keep up with others, he had never suffered from muscle cramps and myoglobinuria after exertion. In particular, during gymnasium classes at school, group play activities and running up two to three flights of stairs, he felt increasing weakness, nausea, and vomiting, but never muscle spasms and myoglobinuria. Nausea and vomiting with or without intense gastric pain and backache are the prodromal features of myoglobinuria and acute renal obstruction associated with intense exercise in PFK-deficient patients. One of his now deceased sisters apparently had similar problems. She also began experiencing chronic, progressive weakness of both extremities at age 74, and died of complications associated with a pelvic fracture at age 84. Clinical details of the case will be described elsewhere (Danon, M. J., S. DiMauro, N. Bresolin, S. Shanske, and S. Vora. Submitted for publication).
The blood specimens from the patient were studied intermittently over the last 3 yr. Chromatographic separation ofPFK isozymes. PFK isozymes were resolved by using DEAE-Sephadex A-25 ion-exchange chromatography at 4VC as described previously (1, 10) . Briefly, a 1.6 X 30-cm column was equilibrated in 0.1 M Tris-phosphate buffer (pH 8.0), containing 25 mM NaCl, 0.2 mM EDTA, 0.2 mM AMP, and 0.7 mM dithiothreitol. The column was loaded with hemolysates containing 0.1-0.12 U (-1 jig PFK considering a specific activity of 100 U/mg).
A 300-ml concave elution gradient of NaCI was prepared by using three chambers of a Varigrad nine-chambered gradient mixer, as described previously (10) . A total of 100 X 3 ml fractions were collected and assayed for PFK activity. By this technique, the three homotetrainers are clearly distinguished from one another by their relative positions of elution. M4 tetramer is eluted first at 214 mosmol/kg (-40th fraction), and L4 tetramer is eluted last at 480 mosmol/kg ( 75th fraction), whereas P4 tetramer is eluted very close to M4 tetramer, at 244 mosmol/kg (-47th fractions) (1, 2, 10). It is noteworthy that the resolution of various isozymes is not feasible if > 0. 15 
Gelfiltration chromatography. To assess the aggregation state and hence molecular weight ofthe PFK isozymes resolved by ion-exchange chromatography, gel filtration studies were undertaken employing the frontal elution technique described by Winzor (11) and applied to mammalian PFK by various investigators (12-15). Pilot experiments were undertaken to investigate various gel filtration matrices (Sepharose 4B, Sephadex G-200, and Ultrogel AcA 22) for their suitability for frontal elution chromatography of PFK using several different column sizes (1 X 30, 1.5 X 30, 2.6 X 30 cm). Because of the high separation efficiency and high mechanical strength, Ultrogel AcA 22 was chosen for frontal elution procedure. Experiments were performed at 4°C with a 1.5 X 30 cm Ultrogel AcA 22 column equilibrated with the very same buffer used for ion-exchange chromatography. The column was packed and eluted exactly according to the manufacturer's instructions. Before the frontal elution studies, hemoglobin was removed from freshly prepared hemolysates using a 1.0 X 10-cm DEAE-Sephadex A-25 ion exchange column equilibrated with the standard column buffer. The column was loaded with 3 ml of hemolysate containing 1.7 U/ml PFK. The hemoglobin was eluted in 25 ml of column buffer. No PFK was present in the hemoglobin effluent. To elute the PFK, the column was rinsed with 10 ml of standard column buffer containing 0.3 M NaCl. A total of 5 X 2-ml fractions were collected and assayed for PFK activity. The peak was observed in fraction number 3 at 264 mosmol/kg H20. The peak PFK fraction was diluted in the column buffer to yield a concentration of 0.008 U/ml. The diluted enzyme solution was then continuously applied to the column until the catalytic activity in the effluent was the same as that ofthe applied sample. The bed volume was constant during all the experiments and constant volume fractions of 1.0 ml were collected with the aid of an Ultrorac 2000 (LKB Instruments, Inc.); flow rate was 10 ml/h. To determine the relative Mr of PFK at a concentraton of 0.008 U/mi, ferritin (Mr = 440,000) and aldolase (Mr = 158,000) were used as molecular weight markers.
Enzyme immunoprecipitation assays. The presence of M-containing isozymes in the patient's red cells was confirmed by active enzyme immunoprecipitation assay utilizing the monoclonal anti-M antibody as described previously (3). The anti-M and anti-L antibodies show strict subunit specificity and when used in excess precipitate not only the respective homotetramer but also heterotetramers containing one or more of the homologous subunit(s). For instance, anti-M antibody completely precipitates not only M4 but also the M3L and M2L2 heterotetramers (3) . The precipitated enzyme activities were expressed as percentages of the concurrent controls; only the precipitation values > 7% were considered significant (16). Each hemolysate was tested in duplicate with duplicate controls on several separate occasions. Both normal individuals and classic disease patients served as concurrent controls to confirm the presence of the M subunits in the propositus' hemolysates. The hybrid species and L4 isozyme from the patient's red cells were resolved into two separate pools by linear gradient elution as described previously (1) and subjected to immunoprecipitation stud-ies. Similarly the selected peak fractions of the hybrid isozymes and L4 isozyme were also tested.
Red cell 2,3-DPG and ATP assays. Fresh whole blood was added immediately from the syringe to an equal volume of ice-cold 2 N perchloric acid, and the neutralized supernatant was stored at -20°C. The levels of ATP and 2,3-DPG were measured by spectrophotometry within the next 4-6 d, as described by Beutler (17) .
In vivo stability of residual red cell PFK. In vivo stability of the residual red cell PFK from the patient was assessed by determining the ratio ofenzyme activities ofthe lightest and densest red cell subpopulations separated by using the technique of density-gradient centrifugation. The pure red cell suspensions from the propositus and control individuals were fractionated into populations of increasing mean cell density and presumably age according to the technique described by Vettore et al. (18) .
Results
Hematological and biochemical studies. Table I compares the results of the present studies with those of classic disease patients (5) and a single case of late-onset muscle disease (7) reported in the literature. The propositus showed mild anemia with low normal hemoglobin level and moderate reticulocytosis. His daughter also showed mild anemia but a normal reticulocyte count. PFK activity was 51 and 63% of normal in the red cells from the propositus and his daughter, respectively. Muscle glycogen was mildly elevated in the propositus, whereas red cell 2,3-DPG levels were -50 and -74% in the father and daughter, respectively. Although the propositus showed normal serum uric acid levels, he has suffered from gout since his early twenties; the latter has been well controlled by allopurinal over the years.
Chromatographic studies of red cell PFK. Fig. 1 A shows the representative isozymic profile of red cell PFK from normal individuals. As shown, it consists of a mixture of five isozymes composed of the M and L subunits M4, M3L, M2L2, ML3, and L4. Note that M4 elutes first, L4 last, and the three hybrid isozymes in intermediate positions. Fig. 1 In contrast, the residual red cell PFK from the propositus, although consisting predominantly of the L4 isozyme, also shows a few early-eluting species that appear to be hybrids composed of M + L subunits (Fig. 1 C) . His daughter's red cell PFK shows a similar chromatographic profile except for a greater proportion of the hybrid isozymes that also elute earlier as compared with those ofher father's red cell PFK (Fig.  I D) . Gelfiltration studies. As shown in Fig. 2 , PFK solution at a concentration of 0.008 U/ml (0.8 ,g/ml) eluted after ferritin (Mr = 440,000) and before aldolase (Mr = 158,000), indicating that the enzyme is a tetramer at this protein concentration. These results are in accord with those of other investigators working with both human red cell (21-23), rabbit red cell (24), and rat liver (15, 16) PFKs. During ion-exchange chromatography, the enzyme concentrations of the various fractions range from 0.001 to 0.015 U/ml, i.e., 10 ng to 150 ng/ml. Since, at these concentrations, PFK exists as a tetramer, we conclude that the isozymic species eluting earlier than L4 isozyme are also tetramers and not polymers of the L4 isozyme. Immunologic studies. The presence of M subunit-containing isozymes in the red cells from the patient and his daughter was confirmed by immunoprecipitation studies. As shown in Table II , anti-M monoclonal antibody precipitates -44 and -56% of PFK activity from patient and his daughter as compared with -82% from normal individuals and none from patients with the typical disease. As expected, the residual red cell PFK from concurrently studied classic disease patients also showed a total lack of precipitation by anti-M antibody. In contrast, anti-L antibody precipitates -90% of red cell PFK from both groups of patients and normal individuals. As shown in Table III , the separated pools of pure L4 and non-L4 (hybrid) isozymes and various peak fractions thereof from In contrast, the hybrid isozyme peaks and pool were precipitated 80-90% by both anti-M and anti-L antibodies.
In vivo stability ofresidual red cell PFK. The PFK activity ratio ofthe youngest ( 15% of(the total) to the oldest red cells (~.. 15% of the total) in the propositus was comparable with that of control subjects, i.e., 1. (5, 30) . In each case, a total lack of the M subunit resulted in the pathognomonic presence of isolated liver-type isozyme in the red cells (Fig. 1  B) . So uniform is this feature that we have been able to make a precise diagnosis of muscle PFK deficiency in several kindreds by investigating their red cells only for the presence of muscle PFK subunits (Vora, S., unpublished data). In each case, the muscle disease was typified by easy fatigability and episodic muscle weakness, cramps, and myoglobinuria after exertion. In contrast, including the patient reported in this article, only three cases of muscle PFK deficiency presenting with late-onset muscle disease are known (7, 9) . The patient reported by Hays et al. (7) had suffered from mild exercise intolerance all her life, but without muscle cramps or myoglobinuria. She presented at age 61 with chronic and progressive limb-girdle weakness of five years' duration. Hematologically and biochemically, she resembled the patients with the typical disease, but no studies were undertaken to precisely define the nature of her enzymatic lesion.
The results of the various studies in the present patient and his daughter, those available in the other patient with lateonset myopathy (7) and in three patients with the typical early-onset disease (5) are compared in Tables I and IV and Fig. 1 (Fig. 1 C) . His daughter's red cells showed an almost identical isozyme profile except for a greater amount of the hybrid species (Fig. 1 D) . The presence of a minor amount of the M subunit in red cells of father and daughter was confirmed by immunological means. The residual red cell PFK from patients with the classic disease is not precipitated by the anti-M monoclonal antibody, indicating a total lack of the catalytically active M subunit. In contrast, 40% and 60% of the red cell PFK from the patient and his daughter are precipitated by the anti-M antibody (Table II) . A contamination ofthe anti-M antibody by anti-L antibody was ruled out by the fact that, as expected, the red cell PFK from two classic disease patients studied concurrently was totally resistant to precipitation. These studies thus rigorously established the existence of the M-type subunits in the patient's red cells.
Mammalian PFKs are known to undergo self-association into high-molecular weight polytetramers that are enzymatically active (14, (31) (32) (33) . This self-association is governed by protein concentration, pH, and effector and salt concentrations (32). Muscle PFK shows aggregation at concentrations > 0.5 mg/ml (31, 33) , whereas the liver (13, 14) and red cell (19) (20) (21) (22) PFKs show aggregation at much lower concentrations, i.e., -1 tg/ml and higher. Despite this extreme propensity for self-aggregation, the red cell PFK from the rabbit in native hemolysates (22) and purified red cell enzyme from humans (19) in very dilute enzyme preparations (0.3 jig/ml) exist as tetramers (Mr = -340,000), as illustrated by active enzyme centrifugation and gel filtration studies. To confirm that the early-eluting isozymes from patient's red cells were not aggregated forms of L4 isozyme or hybrids of M + L subunits, we undertook gel filtration studies employing frontal elution chromatography (Fig. 2) . Our results show that the enzyme at a concentration of 0.08 gg/ml elutes after ferritin (Mr = 440,000) and before aldolase (Mr = 158,000), indicating that at this concentration it exists as a tetramer (Mr = 330,000). These results are in accord with those of others (12-15, [19] [20] [21] [22] and provide additional evidence for the tetrameric nature of PFK during our conditions of chromatography. The fact that early-eluting isozymes are indeed hybrids of M + L subunits was evidenced by the immunoprecipitation studies of the isolated pools of L4 and non-L4 isozymes as well as selected peak fractions thereof (Table III) . These results combined with those of chromatographic studies conclusively confirm the presence of heterotetramers containing the M subunit in red cells from the propositus.
These data indicate that the myopathic syndrome in our patient results from a mutation of the M subunit that is dis- 
